Orexo develops pharmaceuticals and digital therapies focused on addressing unmet needs within the growing space of mental illness and substance use disorders. Orexo’s digital therapeutics share several common features such as digitized counseling (CBT), products supported by published peer reviewed clinical evidence, digital programs that are highly adaptable to both a patients personal and clinical situation, and powered to deliver “Individualized therapy” tailored by an AI engine.